The US Supreme Court ruling in Monsanto v. Durnell represents a major turning point for Bayer. By materially weakening the core failure-to-warn claims that have driven much of the Roundup litigation, the decision significantly reduces one of the company’s largest long-tail risks. In our latest flash report, we explain why this reinforces our constructive stance on Bayer senior unsecured bonds, while also highlighting the remaining risks: the Missouri settlement still needs to be finalized, some residual legal claims may survive, and part of the market rally has already happened. Overall, Bayer’s credit story has clearly improved. The company now looks less like a credit dominated by uncontrollable litigation risk and more like a complex but investable issuer with improving legal visibility.
Don’t miss our latest publication! Discover us on www.bridport.ch
